Trained innate immunity as underlying mechanism for the long-term, nonspecific effects of vaccines (Q38543488)

4 September 2017

1 reference

title

Trained innate immunity as underlying mechanism for the long-term, nonspecific effects of vaccines (English)

1 reference

4 September 2017

3

Reinout van Crevel

0 references

Christine Stabell Benn

series ordinal

4

object named as

Christine Stabell Benn

1 reference

4 September 2017

5

Mihai G Netea

1 reference

4 September 2017

Bastiaan A Blok

1

1 reference

PubMed ID

26150551

4 September 2017

Rob J W Arts

series ordinal

2

1 reference

4 September 2017

6 July 2015

1 reference

Journal of Leukocyte Biology

4 September 2017

10

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

4 September 2017

98

1 reference

4 September 2017

347-356

1 reference

4 September 2017

3

1 reference

Pattern recognition receptors and inflammation

4 September 2017

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Molecular regulation of effector and memory T cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Nonspecific effects of neonatal and infant vaccination: public-health, immunological and conceptual challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Trained immunity: a memory for innate host defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Innate immune memory: towards a better understanding of host defense mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Candida albicans infection affords protection against reinfection via functional reprogramming of monocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Trained immunity or tolerance: opposing functional programs induced in human monocytes after engagement of various pattern recognition receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Regulation of glucose metabolism in T cells: new insight into the role of Phosphoinositide 3-kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

mTOR- and HIF-1α-mediated aerobic glycolysis as metabolic basis for trained immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Long-lasting effects of BCG vaccination on both heterologous Th1/Th17 responses and innate trained immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

A small jab - a big effect: nonspecific immunomodulation by vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

BCG-induced protection: effects on innate immune memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Application of viable bacille Calmette-Guérin topically as a potential therapeutic modality in condylomata acuminata: a placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Treatment of recalcitrant warts with Bacillus Calmette-Guérin: a promising new approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Potential health effects from non-specific stimulation of the immune function in early age: the example of BCG vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Proof-of-concept, randomized, controlled clinical trial of Bacillus-Calmette-Guerin for treatment of long-term type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Studies on fractions of methanol extracts of tubercle bacilli. I. Fractions which increase resistance to infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Effects of cellular constituents of mycobacteria on the resistance of mice to heterologous infections I. Protective effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Enhanced resistance of mice to infection with Pasteurella pestis following vaccination with fractions of phenol-killed tubercle bacilli

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

STUDIES ON THE HETEROLOGOUS IMMUNOGENICITY OF A MENTHANOL-INSOLUBLE FRACTION OF ATTENUATED TUBERCLE BACILLI (BCG). I. ANTIMICROBIAL PROTECTION

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Enhancement of non-specific resistance to viral infection by muramyldipeptide and its analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Protective activity of fractions of tubercle bacilli against isologous tumours in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

The non-specific effects of vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Nonspecific effects of vaccines and the reduction of mortality in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

BCG scar and positive tuberculin reaction associated with reduced child mortality in West Africa. A non-specific beneficial effect of BCG?

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

BCG vaccination scar associated with better childhood survival in Guinea-Bissau

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Routine vaccinations and child survival: follow up study in Guinea-Bissau, West Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Evaluation of non-specific effects of infant immunizations on early infant mortality in a southern Indian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Non-specific and sex-differential effects of vaccinations on child survival in rural western India

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Randomized trial of BCG vaccination at birth to low-birth-weight children: beneficial nonspecific effects in the neonatal period?

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Small randomized trial among low-birth-weight children receiving bacillus Calmette-Guérin vaccination at first health center contact

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Acute lower respiratory tract infections and respiratory syncytial virus in infants in Guinea-Bissau: a beneficial effect of BCG vaccination for girls community based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Effect of revaccination with BCG in early childhood on mortality: randomised trial in Guinea-Bissau

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Vaccination and heterologous immunity: educating the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

CD4 T-cell-mediated heterologous immunity between mycobacteria and poxviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Bystander activation of CD8+ T cells contributes to the rapid production of IFN-gamma in response to bacterial pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Contribution of CD8+ T cells to innate immunity: IFN-gamma secretion induced by IL-12 and IL-18.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Memory CD8+ T cells provide innate immune protection against Listeria monocytogenes in the absence of cognate antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Tyk2-dependent bystander activation of conventional and nonconventional Th1 cell subsets contributes to innate host defense against Listeria monocytogenes infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Naive and innate memory phenotype CD4+ T cells have different requirements for active Itk for their development

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Immunodominant PstS1 antigen of mycobacterium tuberculosis is a potent biological response modifier for the treatment of bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Non-specific effect of Bacille Calmette-Guérin vaccine on the immune response to routine immunisations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

The role of BCG/PPD-activated macrophages in resistance against systemic candidiasis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Molecular analysis of non-specific protection against murine malaria induced by BCG vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

BCG-induced trained immunity in NK cells: Role for non-specific protection to infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Induction of granulysin and perforin cytolytic mediator expression in 10-week-old infants vaccinated with BCG at birth

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Heterologous immunological effects of early BCG vaccination in low-birth-weight infants in Guinea-Bissau: a randomized-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Tumor associated macrophages polarization dictates the efficacy of BCG instillation in non-muscle invasive urothelial bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

On birth single dose live attenuated OPV and BCG vaccination induces gut cathelicidin LL37 responses at 6 week of age: a natural experiment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Autophagy controls BCG-induced trained immunity and the response to intravesical BCG therapy for bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Yellow fever vaccination: is one dose always enough?

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Subdoses of 17DD yellow fever vaccine elicit equivalent virological/immunological kinetics timeline

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Co-administration of live measles and yellow fever vaccines and inactivated pentavalent vaccines is associated with increased mortality compared with measles and yellow fever vaccines only. An observational study from Guinea-Bissau

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Characterization of main cytokine sources from the innate and adaptive immune responses following primary 17DD yellow fever vaccination in adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Innate immunity phenotypic features point toward simultaneous raise of activation and modulation events following 17DD live attenuated yellow fever first-time vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

TLR expression and NK cell activation after human yellow fever vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Perioperative influenza vaccination reduces postoperative metastatic disease by reversing surgery-induced dysfunction in natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Viral entry route determines how human plasmacytoid dendritic cells produce type I interferons

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Toll-like receptor-mediated induction of type I interferon in plasmacytoid dendritic cells requires the rapamycin-sensitive PI(3)K-mTOR-p70S6K pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Pathophysiologic and transcriptomic analyses of viscerotropic yellow fever in a rhesus macaque model

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Distinct gene expression profiles in peripheral blood mononuclear cells from patients infected with vaccinia virus, yellow fever 17D virus, or upper respiratory infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

The Xs and Y of immune responses to viral vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Seasonal inactivated influenza virus vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Prolonged proinflammatory cytokine production in monocytes modulated by interleukin 10 after influenza vaccination in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Live attenuated influenza vaccine (LAIV) impacts innate and adaptive immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Superior immunogenicity of inactivated whole virus H5N1 influenza vaccine is primarily controlled by Toll-like receptor signalling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Expansion of 2B4+ natural killer (NK) cells and decrease in NKp46+ NK cells in response to influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

The immunology of smallpox vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Vaccinia scars associated with better survival for adults. An observational study from Guinea-Bissau

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Vaccinia scars associated with improved survival among adults in rural Guinea-Bissau

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Vaccination history and risk of non-Hodgkin lymphoma: a population-based, case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Inverse association between melanoma and previous vaccinations against tuberculosis and smallpox: results of the FEBIM study

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Protection against melanoma by vaccination with Bacille Calmette-Guerin (BCG) and/or vaccinia: an epidemiology-based hypothesis on the nature of a melanoma risk factor and its immunological control

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Vaccinia virus infection attenuates innate immune responses and antigen presentation by epidermal dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Vaccinia virus infection induces dendritic cell maturation but inhibits antigen presentation by MHC class II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Modified Vaccinia virus Ankara: innate immune activation and induction of cellular signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Detection of a TLR2 agonist by hematopoietic stem and progenitor cells impacts the function of the macrophages they produce

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Non-specific effects of standard measles vaccine at 4.5 and 9 months of age on childhood mortality: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

The optimal age of measles immunisation in low-income countries: a secondary analysis of the assumptions underlying the current policy

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

A randomized trial of a standard dose of Edmonston-Zagreb measles vaccine given at 4.5 months of age: effect on total hospital admissions

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

The impact of childhood vaccines on bacterial carriage in the nasopharynx: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Measles virus-induced immunosuppression: from effectors to mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Measles immune suppression: lessons from the macaque model

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Measles virus-dendritic cell interaction via SLAM inhibits innate immunity: selective signaling through TLR4 but not other TLRs mediates suppression of IL-12 synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Suppression of NF-kappaB and AP-1 activation in monocytic cells persistently infected with measles virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Hemagglutinin protein of wild-type measles virus activates toll-like receptor 2 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Mechanism of up-regulation of human Toll-like receptor 3 secondary to infection of measles virus-attenuated strains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Differential type I IFN-inducing abilities of wild-type versus vaccine strains of measles virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

TLR3 and RIG-I gene variants: associations with functional effects on receptor expression and responses to measles virus and vaccine in vaccinated infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Cytokine production patterns and antibody response to measles vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

The effect of Edmonston-Zagreb and Schwarz measles vaccines on immune response in infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

A randomized trial of an early measles vaccine at 4½ months of age in Guinea-Bissau: sex-differential immunological effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Human papillomavirus immunization is associated with increased expression of different innate immune regulatory receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Increased female-male mortality ratio associated with inactivated polio and diphtheria-tetanus-pertussis vaccines: Observations from vaccination trials in Guinea-Bissau

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Testing the hypothesis that diphtheria-tetanus-pertussis vaccine has negative non-specific and sex-differential effects on child survival in high-mortality countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Community cohort study of rotavirus and other enteropathogens: are routine vaccinations associated with sex-differential incidence rates?

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Community cohort study of Cryptosporidium parvum infections: sex-differential incidences associated with BCG and diphtheria-tetanus-pertussis vaccinations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

Pertussis toxin sensitization alters the pathogenesis of subsequent respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

The immunological effect of revaccination with Bacille Calmette-Guérin vaccine at 19 months of age

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.5RI0315-096R

21 January 2018

Identifiers

DOI

10.1189/JLB.5RI0315-096R

1 reference

4 September 2017

1 reference

PubMed ID

26150551